NCT03629886 2024-03-15Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 StudyGlaxoSmithKlinePhase 4 Completed6,051 enrolled 11 charts